Literature DB >> 11770070

Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart.

O E Brodde1, H Bruck, K Leineweber, T Seyfarth.   

Abstract

The sympathetic and parasympathetic nervous system play a powerful role in controlling cardiac function by activating adrenergic and muscarinic receptors. In the human heart there exist alpha1-, beta1- and beta2-adrenoceptors and M2-muscarinic receptors and possibly also (prejunctional) alpha2-adrenoceptors. Beta1- and beta2-adrenoceptors are quite evenly distributed in the human heart while M2-receptors are heterogeneously distributed (more receptors in atria than in ventricles). Stimulation of beta1- and beta2-adrenoceptors causes increases in heart rate and force of contraction while stimulation of M2-receptors decreases heart rate (directly in atria) and force of contraction (indirectly in ventricles). Pathological situations (such as heart failure) or pharmacological interventions (for example, beta-blocker treatment) can alter the distribution of beta1- and beta2-adrenoceptors in the human heart, while M2-receptors are only marginally affected. On the other hand, relatively little is known on distribution and functional role of alpha1- and alpha2-adrenoceptor subtypes in the human heart.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770070     DOI: 10.1007/s003950170003

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  45 in total

Review 1.  Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning.

Authors:  Michael Zaugg; Marcus C Schaub
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

Review 2.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

3.  Cyclic AMP-dependent inotropic effects are differentially regulated by muscarinic G(i)-dependent constitutive inhibition of adenylyl cyclase in failing rat ventricle.

Authors:  R I Hussain; F Afzal; H K Mørk; J M Aronsen; I Sjaastad; J-B Osnes; T Skomedal; F O Levy; K A Krobert
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 4.  Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions.

Authors:  J A Johnson; S B Liggett
Journal:  Clin Pharmacol Ther       Date:  2011-02-02       Impact factor: 6.875

5.  Hawthorn (Crataegus monogyna Jacq.) extract exhibits atropine-sensitive activity in a cultured cardiomyocyte assay.

Authors:  Satin Salehi; Shannon R Long; Philip J Proteau; Theresa M Filtz
Journal:  J Nat Med       Date:  2008-08-12       Impact factor: 2.343

6.  Influence of vagal control on sex-related differences in left ventricular mechanics and hemodynamics.

Authors:  Alexandra M Williams; Rob E Shave; James M Coulson; Harriet White; Bryn Rosser-Stanford; Neil D Eves
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-01       Impact factor: 4.733

7.  A Genetically Encoded Fluorescent Sensor for Rapid and Specific In Vivo Detection of Norepinephrine.

Authors:  Jiesi Feng; Changmei Zhang; Julieta E Lischinsky; Miao Jing; Jingheng Zhou; Huan Wang; Yajun Zhang; Ao Dong; Zhaofa Wu; Hao Wu; Weiyu Chen; Peng Zhang; Jing Zou; S Andrew Hires; J Julius Zhu; Guohong Cui; Dayu Lin; Jiulin Du; Yulong Li
Journal:  Neuron       Date:  2019-03-25       Impact factor: 17.173

Review 8.  Genetic determinants of response to cardiovascular drugs.

Authors:  Quinn S Wells; Jessica T Delaney; Dan M Roden
Journal:  Curr Opin Cardiol       Date:  2012-05       Impact factor: 2.161

9.  Ventricular arrhythmia risk after subarachnoid hemorrhage.

Authors:  J Michael Frangiskakis; Marilyn Hravnak; Elizabeth A Crago; Masaki Tanabe; Kevin E Kip; John Gorcsan; Michael B Horowitz; Amin B Kassam; Barry London
Journal:  Neurocrit Care       Date:  2009-01-28       Impact factor: 3.210

10.  Phosphatase-1-inhibitor-1: amplifier or attenuator of catecholaminergic stress?

Authors:  Katrin Wittköpper; Thomas Eschenhagen; Ali El-Armouche
Journal:  Basic Res Cardiol       Date:  2010-06-06       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.